Visceral leishmaniasis with haemophagocytic lymphohistiocytosis

BMJ Case Rep. 2019 Feb 13;12(2):e226361. doi: 10.1136/bcr-2018-226361.

Abstract

A 27-year-old man presented with high-grade intermittent fever for 4 months, generalised fatigue for 2 months, intermittent gum bleeds for 1 month and loss of weight of 15 kg. He appeared cachectic with generalised wasting, had pallor and features of reticuloendothelial system proliferation. His liver span was 17 cm. He had massive splenomegaly. His cardiovascular, respiratory and neurological examination were normal. He was diagnosed to have visceral leishmaniasis (VL) based on bone marrow (BM) examination that showed Leishmania donovani (LD) bodies and was treated with liposomal amphotericin (LA). During the course of therapy, he developed bleeding from various mucosal and venepuncture sites. His further evaluation, which included a repeat BM aspirate, showed haemophagocytes. Final diagnosis made was VL with secondary haemophagocytic lymphohistiocytosis. He was continued on LA with intravenous hydrocortisone. He developed refractory distributive shock with multiorgan dysfunction and succumbed to his illness.

Keywords: immunology; medical management; tropical medicine (infectious disease).

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Adult
  • Amphotericin B / administration & dosage*
  • Amphotericin B / therapeutic use
  • Bone Marrow Examination
  • Fever / etiology
  • Humans
  • Hydrocortisone / administration & dosage*
  • Hydrocortisone / therapeutic use
  • Leishmania donovani / isolation & purification
  • Leishmaniasis, Visceral / complications
  • Leishmaniasis, Visceral / drug therapy*
  • Lymphohistiocytosis, Hemophagocytic / drug therapy*
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Male

Substances

  • liposomal amphotericin B
  • Amphotericin B
  • Hydrocortisone